Taisho Pharmaceutical (China) Co., Ltd.
Chinese manufacturing subsidiary of Japan's Taisho Pharmaceutical, producing and distributing the…
Chinese manufacturing subsidiary of Japan's Taisho Pharmaceutical, producing and distributing the Lipovitan energy drink and allied B-vitamin supplement range for the Chinese market. Also manufactures OTC cold and allergy remedies localised for Chinese consumers from a GMP-certified Tianjin facility.
- Type
- Manufacturer
- Location
- Tianjin, China
- Founded
- 1998
- Website
- taisho.cn
- Categories
- Medical & Healthcare Supplies, Supplements & Wellness, Beverages
- Markets
- China, Japan, Hong Kong, Singapore, Taiwan
Verified facts
- debarment-clear (green), checked 2026-08-12 OpenSanctions
- sanctions-clear (green), checked 2026-08-12 OpenSanctions
Claimed certifications
- ISO 9001, Quality Management IAF CertSearch
- Good Manufacturing Practice
- ISO 22000, Food Safety IAF CertSearch
Import rules for these goods
- EU imports of food of animal origin and many other food categories must be pre-notified in TRACES and enter through border control posts. European Commission (TRACES)
- US imports require the foreign facility to be FDA-registered and the importer to run a Foreign Supplier Verification Program (FSVP). US FDA
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)